Company Overview
- Website
- accelevirdx.com
- Employees
- 12
- Founded in
- 2015
- Industry
- BioTech/Drugs
- SIC Code
-
8731 - Commercial Physical and Biological Research
Financials & Stats
Revenue
$10B
Recent News & Media
A First-in-Class Dual Degrader of Bcl-2/Bcl-xL Reverses HIV Latency and Minimizes Ex Vivo Reservoirs from Patients
- Apr 4, 2025
- pmc.ncbi.nlm.nih.gov
A novel quantitative approach for measuring the reservoir of latent HIV-1 proviruses
- Oct 18, 2024
- pmc.ncbi.nlm.nih.gov
HIV-1 Remission after Allogeneic Hematopoietic-Cell Transplantation
- Feb 14, 2024
- nejm.org
Intact Proviral DNA Analysis of the Brain Viral Reservoir and Relationship to Neuroinflammation in People with HIV on Suppressive Antiretroviral Therapy
- Apr 20, 2023
- pmc.ncbi.nlm.nih.gov
Varied Patterns of Decay of Intact Human Immunodeficiency Virus Type 1 Proviruses Over 2 Decades of Antiretroviral Therapy
- Feb 10, 2023
- academic.oup.com
The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a Humanized Mouse Mode
- Nov 30, 2022
- pmc.ncbi.nlm.nih.gov
Accelevir Diagnostics Tech Stack
Companies Similar to Accelevir Diagnostics
Analyze industry trends and opportunities by examining competitors and companies comparable to Accelevir Diagnostics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 59 | Boston, MA | ||
| 10M | 27 | Cambridge, MA | 2010 | |
| 10M | 23 | Waltham, MA | 1999 | |
| 10M | 2 | Boston, MA | ||
| 10M | 46 | Woburn, MA |